AGREEMENT OF MERGER among: SORRENTO THERAPEUTICS, INC., a Delaware corporation; STI MERGER SUB, INC., a Delaware corporation; IGDRASOL, INC., a Delaware corporation; the stockholders of IgDraSol, Inc.; and VUONG TRIEU, as the Stockholders’ Agent....Agreement and Plan of Merger • September 11th, 2013 • Sorrento Therapeutics, Inc. • Services-commercial physical & biological research • Delaware
THIS AGREEMENT AND PLAN OF MERGER (“Agreement”) is made and entered into as of September 9, 2013, by and among: Sorrento Therapeutics, Inc., a Delaware corporation (“Parent”); STI Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”); IgDraSol, Inc., a Delaware corporation (the “Company”); Vuong Trieu as the Stockholders’ Agent and all the stockholders of the Company (each a “Stockholder”). Certain other capitalized terms used in this Agreement are defined in Exhibit A.
